Tag

Rapamycin

All articles tagged with #rapamycin

science1 month ago•3 min saved

New Hypothesis Links Female Reproduction to Longevity via Ovarial Signaling

A new 'reproductive resilience hypothesis' published in Cell suggests that female reproductive tissues actively drive systemic body maintenance, challenging the view that reproduction accelerates aging. Researchers argue that natural selection favors longevity in females to ensure offspring survival, with the ovary acting as a central regulator of health across all tissues. Clinical trials are now testing whether drugs like rapamycin can slow ovarian aging to extend health span.

via medscape.com|

#evolutionary-medicine #longevity #ovarian-aging

health-and-science2 months ago•37 min saved

Canine Trials and Consumer Trends: The Rise of Pet Longevity Science

The pet health sector is shifting toward longevity-focused interventions, driven by both consumer demand for anti-aging treatments and rigorous clinical trials. While pet owners increasingly use rapamycin to extend the lives of dogs and cats, UK-based Genflow Biosciences is advancing a gene therapy trial in beagles that shows early signs of improved survival and biological age markers. This trend reflects a broader move to use companion animals as models for human longevity research, bridging the gap between lab studies and real-world outcomes.

via Bloomberg|

#gene-therapy #health-and-science #longevity-research

science2 months ago•4 min saved

One-Dose Rapamycin Triggers Rapid Reversal of Autism-Like Brain Activity in Adult Mice

A single dose of rapamycin given to adult mice exposed to maternal inflammation reverses most autism-like brain and behavioral changes within about two hours by rapidly normalizing neural activity and network patterns, likely through dampening mTOR signaling and restoring excitation–inhibition balance. The effects are fast but temporary and do not repair underlying structural brain changes; long-term use carries toxicity risks, but the findings point to new targets such as sensory circuit modulation rather than rapamycin itself.

via SciTechDaily|

#autism #brain-networks #maternal-inflammation

science2 months ago•8 min saved

Single Dose of Rapamycin Rapidly Reverses Autism-Like Symptoms in Adult Mice

Maternal inflammation during pregnancy induces lasting autism-like brain changes in mice; a single dose of rapamycin quickly normalized neuronal activity, reduced seizures, and improved sensory processing and repetitive behaviors within about two hours. The effects were temporary and rapamycin is not a practical human treatment, but the study highlights the brain's functional adaptability and points to new targets in mTOR signaling and circuit modulation.

via ScienceDaily|

#autism #mice #neural-circuits

science2 months ago•7 min saved

Two-Hour Reversal of Autism-Like Traits in Mice Points to Circuit-Level Therapies

In a mouse model of maternal immune activation, a single dose of rapamycin rapidly normalized neuronal activity, reduced seizure susceptibility, improved brain network connectivity, and lessened autism-like behaviors within about two hours. Since this window is too short for structural brain changes, the results reveal adult functional plasticity and point to therapeutic targets in mTOR signaling, neuronal excitation balance, and sensory circuits—though rapamycin itself is not suitable for humans due to toxicity and tolerance, guiding safer circuit-focused approaches.

via Neuroscience News|

#autism #maternal-inflammation #mtor

technology3 months ago•6 min saved

Longevity hype meets medical reality in Silicon Valley as a flagship experiment pauses

Silicon Valley’s longevity movement gets a reality check as Bryan Johnson halted Rapamycin after years of self-testing, highlighting the gap between hype and proven science: there’s no clinical evidence that any current intervention extends human life, and much of the field rests on self-reported data and individualized tests rather than large-scale trials, even as tech culture pushes rapid experimentation and interest in aging-related drugs like metformin and GLP-1 inhibitors continues.

via TechSpot|

#longevity #mtor #rapamycin

health5 months ago•20 min saved

Rapamycin Could Dull Exercise Gains, Study Finds

A Washington Post Well+Being study finds that rapamycin, a longevity drug, may blunt the health benefits of exercise, with older adults taking the drug showing less strength and functional gains from training than those on placebo, suggesting off‑label use for lifespan extension could impair muscle adaptation via the mTOR pathway.

via The Washington Post|

#aging #exercise #fda

science7 months ago•6 min saved

Ralph’s Dementia Helps Uncover Aging Secrets Across Dogs and Humans

Ralph, a beloved family dog, developed dementia and joined the Dog Aging Project, a large study of aging in dogs that aims to illuminate human neurodegenerative diseases. Scientists compare dog and human brains to understand dementia, noting similar structural changes and brain shrinkage. Memory tests and MRI scans underscored Ralph’s cognitive decline, while a pilot rapamycin trial suggested reduced brain inflammation in treated dogs. After Ralph’s death, researchers continued posthumous brain analysis, reinforcing the potential of canine aging research to inform human health. The Rowe family finds purpose in Ralph’s contribution to science and encourages keeping dogs mentally and physically active for brain health.

via CBS News|

#aging #dementia #dog-aging-project

sciencehealth7 months ago•11 min saved

Canine aging study aims to unlock healthier, longer lives for all

The Dog Aging Project tracks 50,000+ dogs to study aging and dementia, linking lifestyle factors to disease risk and showing that canine brain aging shares features with human dementia. The effort includes diets, exercise, blood work, and brain MRIs, plus brain donations for analysis. Early findings suggest dogs living with others and remaining active have fewer diseases, and a pilot rapamycin study showed reduced brain inflammation in some dogs, prompting larger NIH-funded trials and the push to develop dog-focused longevity therapies.

via CBS News|

#aging #dementia #dog-aging-project

science1 year ago•3 min saved

New Longevity Drug Shows Promise Without Diet Restrictions

A new study finds that Rapamycin, originally an immunosuppressant, extends lifespan in eight vertebrate species as effectively as dietary restriction, while Metformin shows no clear benefit, highlighting Rapamycin's potential in aging research.

via SciTechDaily|

#aging #dietary-restriction #lifespan

science1 year ago•6 min saved

Rapamycin and Calorie Restriction: New Insights into Extending Lifespan

A meta-analysis suggests that rapamycin may extend lifespan in animals similarly to dietary restrictions, unlike metformin, but human trials are needed to confirm its effects and safety for longevity in people.

via Medical News Today|

#animal-studies #dietary-restriction #lifespan-extension

science1 year ago•3 min saved

Scientists Confirm Anti-Aging Drug Extends Animal Lifespan

Scientists found that rapamycin, a drug that mimics the effects of dieting, can extend lifespan in animals almost as effectively as actual calorie restriction, whereas metformin does not show the same benefit. While promising, more research is needed to confirm safety and effectiveness in humans, and current evidence is primarily from animal studies.

via ScienceAlert|

#anti-aging #diet-mimicking-drugs #longevity

health1 year ago•4 min saved

Rapamycin Extends Lifespan Nearly as Much as Calorie Restriction

A recent study shows that rapamycin extends lifespan almost as effectively as calorie restriction in animals, making it a promising anti-aging drug, while metformin shows less consistent benefits. However, more research is needed, especially in humans, to confirm safety and efficacy.

via ZME Science|

#anti-aging #calorie-restriction #health

health1 year ago•3 min saved

Rapamycin and Blood Pressure Drugs Show Promising Anti-Aging Benefits

A new study shows that rapamycin extends lifespan almost as effectively as calorie restriction in animals, unlike metformin, which shows no clear benefit. While promising, more research is needed to confirm safety and efficacy in humans, and current evidence is primarily from animal studies.

via The Conversation|

#anti-ageing #dietary-restriction #health

science1 year ago•3 min saved

Combination Drug Extends Mouse Lifespan by 30%

Scientists in Europe found that a cocktail of two cancer drugs, rapamycin and trametinib, extended mice lifespans by about 30%, improved health markers, and delayed age-related diseases, suggesting potential for human anti-aging therapies, though more research is needed.

via ScienceAlert|

#anti-aging #lifespan-extension #mice